STOCK TITAN

IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a leading medical cannabis company operating in Israel and Germany, has announced it will release its second quarter 2024 financial results on Wednesday, August 14, 2024, before market open. The company will host a zoom web conference at 9:00am ET on the same day to discuss the results and conduct a Q&A session for investors.

Interested parties can register for the zoom call using the provided link. If unable to attend live, a recording of the call will be available on the company's investor relations website within 24 hours after the event. This announcement highlights IMC's commitment to transparency and investor communication regarding its financial performance.

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), una delle principali aziende di cannabis medicinale operanti in Israele e Germania, ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 il mercoledì 14 agosto 2024, prima dell'apertura del mercato. L'azienda terrà una video conferenza su Zoom alle 9:00 ET lo stesso giorno per discutere i risultati e condurre una sessione di domande e risposte per gli investitori.

Le parti interessate possono registrarsi per la chiamata Zoom utilizzando il link fornito. Se non sarà possibile partecipare dal vivo, una registrazione della chiamata sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda entro 24 ore dopo l'evento. Questo annuncio evidenzia l'impegno di IMC per la trasparenza e la comunicazione con gli investitori riguardo alla propria performance finanziaria.

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), una de las principales empresas de cannabis médico que opera en Israel y Alemania, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el miércoles 14 de agosto de 2024, antes de la apertura del mercado. La empresa llevará a cabo una videoconferencia por Zoom a las 9:00 a.m. ET el mismo día para discutir los resultados y realizar una sesión de preguntas y respuestas para los inversores.

Las partes interesadas pueden registrarse para la llamada por Zoom utilizando el enlace proporcionado. Si no puede asistir en vivo, una grabación de la llamada estará disponible en el sitio web de relaciones con inversores de la empresa dentro de las 24 horas posteriores al evento. Este anuncio destaca el compromiso de IMC con la transparencia y la comunicación con los inversores sobre su rendimiento financiero.

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC)는 이스라엘과 독일에서 운영되는 주요 의료용 대마초 회사로, 2024년 2분기 재무 결과2024년 8월 14일 수요일, 시장 개장 전에 발표할 예정이라고 발표했습니다. 회사는 같은 날 오전 9시 ET에 Zoom 웹 회의를 개최하여 결과를 논의하고 투자자들을 위한 Q&A 세션을 진행할 것입니다.

관심 있는 분들은 제공된 링크를 통해 Zoom 통화에 등록할 수 있습니다. 실시간으로 참석할 수 없는 경우, 행사 후 24시간 이내에 회사의 투자자 관계 웹사이트에서 통화 녹음이 제공될 예정입니다. 이번 발표는 IMC가 재무 성과에 대한 투명성과 투자자 소통에 대한 헌신을 강조하고 있습니다.

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), une entreprise leader dans le domaine du cannabis médical opérant en Israël et en Allemagne, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 le mercredi 14 août 2024, avant l'ouverture du marché. L'entreprise organisera une conférence web Zoom à 9h00 ET le même jour pour discuter des résultats et mener une séance de questions-réponses pour les investisseurs.

Les parties intéressées peuvent s'inscrire à l'appel Zoom en utilisant le lien fourni. Si vous ne pouvez pas assister en direct, un enregistrement de l'appel sera disponible sur le site web des relations avec les investisseurs de l'entreprise dans les 24 heures suivant l'événement. Cette annonce souligne l'engagement d'IMC envers la transparence et la communication avec les investisseurs concernant sa performance financière.

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), ein führendes Unternehmen im Bereich medizinisches Cannabis, das in Israel und Deutschland tätig ist, hat angekündigt, dass es am Mittwoch, den 14. August 2024, vor Markteröffnung seine Finanzergebnisse für das zweite Quartal 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 9:00 Uhr ET ein Zoom-Webinar veranstalten, um die Ergebnisse zu erörtern und eine Fragerunde für Investoren durchzuführen.

Interessierte Parteien können sich über den bereitgestellten Link für den Zoom-Anruf anmelden. Falls eine Teilnahme live nicht möglich ist, wird eine Aufzeichnung des Anrufs innerhalb von 24 Stunden nach der Veranstaltung auf der Website der Investor Relations des Unternehmens verfügbar sein. Diese Ankündigung hebt IMCs Engagement für Transparenz und Kommunikation mit Investoren in Bezug auf die finanzielle Leistung hervor.

Positive
  • Timely financial reporting indicates transparency and good corporate governance
  • Hosting a web conference shows commitment to investor communication
Negative
  • None.

TORONTO and GLIL YAM, Israel, Aug. 6, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter 2024 ended June 30, 2024, on Wednesday, August 14, 2024, before the market opens.

IM Cannabis Corp. Logo

The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com/ within 24 hours after the call.

Link for the to register for the zoom call: https://us02web.zoom.us/webinar/register/WN_W9nYbBB4R7CREuqN9dGOag

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com

Logo - https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

 

Cision View original content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-second-quarter-2024-financial-results-on-wednesday-august-14th-at-900am-et-302215408.html

SOURCE IM Cannabis Corp.

FAQ

When will IM Cannabis (IMCC) report its Q2 2024 financial results?

IM Cannabis (IMCC) will report its second quarter 2024 financial results on Wednesday, August 14, 2024, before the market opens.

What time is the IM Cannabis (IMCC) Q2 2024 earnings call?

IM Cannabis (IMCC) will host a zoom web conference to discuss Q2 2024 results on Wednesday, August 14, 2024, at 9:00am ET.

How can investors join the IM Cannabis (IMCC) Q2 2024 earnings call?

Investors can register for the IM Cannabis (IMCC) Q2 2024 earnings call by clicking the link provided in the press release.

Where can I find a recording of the IM Cannabis (IMCC) Q2 2024 earnings call?

A recording of the IM Cannabis (IMCC) Q2 2024 earnings call will be available on the company's investor relations website (https://investors.imcannabis.com/) within 24 hours after the call.

IM Cannabis Corp. Common Shares

NASDAQ:IMCC

IMCC Rankings

IMCC Latest News

IMCC Stock Data

6.15M
878.59k
47%
6.13%
0.13%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Tel Aviv